he would caress her arm and repeatedly tell her, "babe, babe, it's ok." .
recommended: .: "arise: a phase 3 randomized trial of erenumab for episodic migraine." .
marketwatch: "new migraine drugs have promise -- and a ,500 price tag." .
following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv). . .
-
.